A Possible Effect of Oxytocin During Interaction Between Humans and Animals

Overview

The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Basic Science
    • Masking: None (Open Label)
  • Study Primary Completion Date: November 2011

Detailed Description

The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals and filling in instruments measuring anxiety and stress.

Interventions

  • Other: Measuring oxytocin level in blood
    • Blood sampling and instruments measuring anxiety and stress

Clinical Trial Outcome Measures

Primary Measures

  • Measuring the possible change in Oxytocin level in human blood during intervention with farm animals.
    • Time Frame: Start medio October 2010, and end December 2011 (14 months)
    • Blood sampling will be drawn at baseline, before intervention starts, and 5 minutes after start. 3rd sample will be drawn 15 minutes after start. Total time of intervention is 15 minutes.

Secondary Measures

  • Self evaluation of anxiety and coping strategies.
    • Time Frame: Start medio October 2010, and end December 2011 (14 months)
    • Spielberger State Anxiety Inventory (SSAI) (Spielberger et al, 1979)and Coping Strategies Scale of the Pressure Management Indicator (Williams & Cooper, 1998.

Participating in This Clinical Trial

Inclusion Criteria

  • woman – age 20-30 years old – physical capable of being in a farm environment and have contact with cows Exclusion Criteria:

  • pregnancy – breastfeeding – anxiety for blood sampling – anxiety for animals – allergies – psychiatric diagnoses – medication

Gender Eligibility: Female

Minimum Age: 20 Years

Maximum Age: 30 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Norwegian University of Life Sciences
  • Provider of Information About this Clinical Study
    • Principal Investigator: Gunn Pedersen, MPh – Norwegian University of Life Sciences
  • Overall Official(s)
    • Bente Berget, PhD, Principal Investigator, Norwegian University of Life Sciences

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.